Home Ingredients AHCC (Active Hexose Correlated Compound)
Immune SupportWomen's Health

AHCC (Active Hexose Correlated Compound)

Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

AHCC is a proprietary fermented mushroom mycelium extract — primarily from shiitake (Lentinula edodes) and other basidiomycetes — developed by Amino Up Co. (Japan) since 1989. Distinguished from whole mushroom extracts by acetylated alpha-glucan (rather than typical beta-glucan) as primary active. Most clinically-studied for HPV (human papillomavirus) clearance, immune support during chemotherapy, and infection adjunct. Substantial clinical research base for a mushroom-derived supplement.

Studied Dose 1-3 g/day; 3 g/day used in HPV clearance trials (Smith 2019 — 6 months); 1-3 g/day for immune support
Active Compound Alpha-glucan oligosaccharides (acetylated; ~20% of extract); other polysaccharides

Benefits

HPV Clearance

pilot trial of AHCC (3 g/day for 6 months) in 22 women with persistent HPV infection — 41% achieved HPV clearance + sustained negative for 6 months. Phase 2 RCT ongoing. Notable as one of few supplements with prospective HPV clearance evidence.

Supported by Trial 1

Chemotherapy Adjunct (Quality of Life, Outcomes)

Multiple Japanese trials show AHCC improves QoL during chemotherapy, reduces side effects, and may improve outcomes in liver cancer (HCC) and other cancers. Used widely in Japanese integrative oncology.

Supported by Trial 2

Immune Cell Activation

Increases NK cell activity, T-cell function, dendritic cell function. Mechanism well-characterized. Modest but real immune activation.

Liver Function Protection

Some evidence for hepatoprotective effects, particularly during chemotherapy and viral hepatitis. trial showed reduced liver enzyme elevation during interferon therapy.

Supported by Trial 2

Infection Adjunct (Various)

Some evidence for modest adjunctive benefit in influenza, HIV (immune support), and other chronic infections. Not standalone treatment for these conditions.

Supported by Trial 1, Trial 2

Mechanism of action

1

Acetylated Alpha-Glucan Active

AHCC's distinctive feature is acetylated alpha-glucan oligosaccharides (~20% of extract) — different from typical mushroom beta-glucans (lentinan, MD-fraction, etc.). Theoretical advantage: alpha-glucan oligosaccharides may have better oral absorption than complex beta-glucan polymers.

2

NK Cell Activation

Increases natural killer (NK) cell activity — innate immune response important for viral infection and tumor surveillance. Multiple trials confirm NK activation.

3

Dendritic Cell Function

Activates dendritic cells — antigen-presenting cells that bridge innate and adaptive immunity. Important for sustained immune responses.

4

Cytokine Modulation

Modulates inflammatory cytokine balance — typically increases Th1 (cellular immunity) cytokines while modulating inflammatory response. Different from indiscriminate immune stimulation.

Clinical trials

1
AHCC for HPV Clearance

Open-label pilot trial of AHCC (3 g/day) for 6 months in 22 women with persistent HPV infection. UT Health Science Center.

22 women with persistent HPV infection.

9 of 22 patients (41%) achieved durable HPV clearance + sustained negative for 6 months post-supplementation. Generated significant interest. Larger phase 2 clinical trial ongoing (NCT02405533).

2
AHCC for Liver Cancer Outcomes

Multiple Japanese trials of AHCC as adjunct in hepatocellular carcinoma (HCC) patients post-resection.

Liver cancer patients.

Improved overall survival, recurrence-free survival, and QoL vs control in some trials. Established AHCC in Japanese integrative oncology.

Side effects and drug interactions

Common Potential side effects

Generally very well-tolerated.
Mild GI distress (nausea, diarrhea, gas) — particularly during initial use.
Headache rare.
Allergic reactions to mushroom rare.
Caution in autoimmune disease (theoretical immune activation concern).
Avoid in transplant patients without medical supervision.

Important Drug interactions

Chemotherapy — used adjunctively in Japan; consult oncologist for specific regimens.
Immunosuppressants — avoid in transplant patients without medical supervision; immune activation opposes intentional immunosuppression.
Anticoagulants — theoretical minor bleeding risk.
Other immune-modulating supplements — additive effects.
CYP3A4 substrates — potentially modest effects (limited data).

More Immune Support Ingredients

Immune Support
Vitamin C
Vitamin C (L-ascorbic acid) is a water-soluble essential nutrient that humans cannot synth…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…
Immune Support
Vitamin A
Vitamin A is a fat-soluble nutrient essential for vision, immune defense, reproduction, an…
Immune Support
EpiCor® (Postbiotic Yeast Fermentate — Cargill)
EpiCor® is a postbiotic ingredient from Cargill — derived from the fermentation of Sacchar…

Explore Other Ingredients

Antioxidant
Setria® Glutathione
Setria® is Kyowa Hakko's patented reduced L-glutathione (GSH) produced via fermentation —…
Antioxidant
Milk Thistle
Milk thistle, derived from the Silybum marianum plant, contains silymarin, a compound know…
Antioxidant
Alpha Lipoic Acid
Alpha-lipoic acid (ALA) is a versatile antioxidant made naturally in the body that is unus…

Frequently asked questions about AHCC (Active Hexose Correlated Compound)

What is AHCC?

AHCC (Active Hexose Correlated Compound) is a standardized extract made from the mycelia of shiitake and other mushrooms, rich in alpha-glucans. It is one of the most studied mushroom-derived immune supplements, popular for immune support.

What is AHCC used for?

It is used mainly for immune support, with research including its use alongside conventional care and studies on supporting the body's response to certain viral challenges (such as HPV). Its alpha-glucans are thought to support immune-cell activity.

How much AHCC should I take?

Studies commonly use about 1 to 3 grams per day, often taken on an empty stomach. Follow the specific product's labeling, as AHCC is a standardized ingredient.

Is AHCC safe?

AHCC has a good safety record in studies and is generally well tolerated; mild digestive upset can occur. Those on immune-modulating medication or undergoing treatment should use it with their doctor's knowledge.

What is the recommended dosage of AHCC?

The clinically studied dose is 1-3 g/day; 3 g/day used in HPV clearance trials (Smith 2019 — 6 months); 1-3 g/day for immune support Always follow the product label and check with a healthcare provider for personal advice.

Is AHCC safe, and does it have side effects?

For most healthy adults, AHCC is well tolerated at studied doses. Reported effects can include: Generally very well-tolerated. Mild GI distress (nausea, diarrhea, gas) — particularly during initial use. It may also interact with some medications. AHCC is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does AHCC interact with any medications?

Possible interactions include: Chemotherapy — used adjunctively in Japan; consult oncologist for specific regimens. Immunosuppressants — avoid in transplant patients without medical supervision; immune activation opposes intentional immunosuppression. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for AHCC?

NutraSmarts rates the evidence for AHCC as Moderate (3 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutr Cancer. 2008;60(5):643-51. doi: 10.1080/01635580801993280.PubMedUsed to support: Double-blind RCT in healthy volunteers in which AHCC produced measurable immunological changes (such as NK and dendritic-cell activity). The main controlled human trial behind the immune-support use.
  2. Smith JA, Gaikwad AA, Mathew L, Rech B, Faro JP, Lucci JA 3rd, Bai Y, Olsen RJ, Byrd TT. AHCC(®) Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections. Front Oncol. 2022;12:881902. doi: 10.3389/fonc.2022.881902.PubMedUsed to support: Clinical study of AHCC supplementation supporting immune clearance of persistent high-risk HPV infection. Supports the immune and women's-health uses, though larger trials are still needed.
  3. Smith JA, Mathew L, Gaikwad A, Rech B, Burney MN, Faro JP, Lucci JA 3rd, Bai Y, Olsen RJ, Byrd TT. From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections. Front Oncol. 2019;9:173. doi: 10.3389/fonc.2019.00173.PubMedUsed to support: Bench-to-bedside pilot evaluating AHCC to modulate host immunity and clear persistent HPV. Early human support for the HPV and immune use.
  4. Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother. 2006;55(10):1258-66. doi: 10.1007/s00262-005-0111-9.PubMedUsed to support: Preclinical study showing AHCC enhances tumor immune surveillance through both innate and adaptive immunity. Mechanistic background only; this is laboratory evidence, not a human outcome.